Ozurdex® (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial

BACKGROUND: Proliferative vitreoretinopathy (PVR) is the commonest cause of late anatomical failure in rhegmatogenous retinal detachment. Visual and anatomical outcomes remain poor despite advances in vitreoretinal surgical techniques with reported primary failure rates of up to nearly 50%. Numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Philip J, Bunce, Catey, Charteris, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874765/
https://www.ncbi.nlm.nih.gov/pubmed/24165545
http://dx.doi.org/10.1186/1745-6215-14-358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874765/
https://www.ncbi.nlm.nih.gov/pubmed/24165545
http://dx.doi.org/10.1186/1745-6215-14-358

Ejemplares similares